Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy. Bourourou M, Gouix E, Melis N, Friard J, et al. J Cereb Blood Flow Metab 2021;41:1080-1090.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bourourou M, Gouix E, Melis N, Friard J, et al. Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy. J Cereb Blood Flow Metab 2021;41:1080-1090.
PMID: 32615885